CEDUR - German IBD Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorImmunoRegister gUG
About this trial
The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.
Eligibility criteria
Qualifiers
Crohn Disease Ulcerative Colitis Indterminate Colitis
Disqualifiers
Other gastrointestinal disorders than above
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1ImmunoRegister gUG20251, Hamburg Germany
Sponsors and collaborators
ImmunoRegister gUG
Lead sponsor
Source ClinicalTrials.gov